Cite
Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice.
MLA
Jung, Jae-Joon, et al. “Matrix Metalloproteinase Inhibitor, Doxycycline and Progression of Calcific Aortic Valve Disease in Hyperlipidemic Mice.” Scientific Reports, Sept. 2016, p. 32659. EBSCOhost, https://doi.org/10.1038/srep32659.
APA
Jung, J.-J., Razavian, M., Kim, H.-Y., Ye, Y., Golestani, R., Toczek, J., Zhang, J., & Sadeghi, M. M. (2016). Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice. Scientific Reports, 32659. https://doi.org/10.1038/srep32659
Chicago
Jung, Jae-Joon, Mahmoud Razavian, Hye-Yeong Kim, Yunpeng Ye, Reza Golestani, Jakub Toczek, Jiasheng Zhang, and Mehran M. Sadeghi. 2016. “Matrix Metalloproteinase Inhibitor, Doxycycline and Progression of Calcific Aortic Valve Disease in Hyperlipidemic Mice.” Scientific Reports, September, 32659. doi:10.1038/srep32659.